Liver metastases: Sulphur hexafluoride-enhanced ultrasonography for lesion detection: a systematic review (Q37783756)

23 August 2017

title

Liver metastases: Sulphur hexafluoride-enhanced ultrasonography for lesion detection: a systematic review (English)

1 reference

23 August 2017

1 reference

1

Paolo Cabassa

1 reference

23 August 2017

Shandra Bipat

2

1 reference

23 August 2017

Laura Longaretti

series ordinal

3

1 reference

23 August 2017

Mario Morone

series ordinal

4

1 reference

23 August 2017

Roberto Maroldi

series ordinal

5

1 reference

23 August 2017

publication date

1 October 2010

1 reference

Ultrasound in Medicine and Biology

23 August 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

23 August 2017

volume

36

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

1561-1567

1 reference

Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Accuracy of investigations for asymptomatic colorectal liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Detection of hepatic metastases from carcinoid tumor: prospective evaluation of contrast-enhanced ultrasonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Liver metastases in cancer: detection with contrast-enhanced ultrasonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

[Detection of liver lesions by contrast-enhanced ultrasound -- comparison to intraoperative findings]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Ultrasound imaging of focal liver lesions with a second-generation contrast agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Characterization of focal liver lesions with contrast-enhanced ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Focal liver lesions: evaluation with contrast-enhanced ultrasonography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

The role of contrast-enhanced ultrasound in the detection of focal liver leasions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

Detection of colorectal cancer hepatic metastases with contrast-enhanced ultrasound: comparison with conventional B-mode ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2010.06.004

10.1016/J.ULTRASMEDBIO.2010.06.004

7 January 2021

Identifiers

DOI

1 reference

23 August 2017

1 reference